Literature DB >> 24760894

Statistical linkage analysis of substitutions in patient-derived sequences of genotype 1a hepatitis C virus nonstructural protein 3 exposes targets for immunogen design.

Ahmed A Quadeer1, Raymond H Y Louie1, Karthik Shekhar2, Arup K Chakraborty3, I-Ming Hsing4, Matthew R McKay5.   

Abstract

UNLABELLED: Chronic hepatitis C virus (HCV) infection is one of the leading causes of liver failure and liver cancer, affecting around 3% of the world's population. The extreme sequence variability of the virus resulting from error-prone replication has thwarted the discovery of a universal prophylactic vaccine. It is known that vigorous and multispecific cellular immune responses, involving both helper CD4(+) and cytotoxic CD8(+) T cells, are associated with the spontaneous clearance of acute HCV infection. Escape mutations in viral epitopes can, however, abrogate protective T-cell responses, leading to viral persistence and associated pathologies. Despite the propensity of the virus to mutate, there might still exist substitutions that incur a fitness cost. In this paper, we identify groups of coevolving residues within HCV nonstructural protein 3 (NS3) by analyzing diverse sequences of this protein using ideas from random matrix theory and associated methods. Our analyses indicate that one of these groups comprises a large percentage of residues for which HCV appears to resist multiple simultaneous substitutions. Targeting multiple residues in this group through vaccine-induced immune responses should either lead to viral recognition or elicit escape substitutions that compromise viral fitness. Our predictions are supported by published clinical data, which suggested that immune genotypes associated with spontaneous clearance of HCV preferentially recognized and targeted this vulnerable group of residues. Moreover, mapping the sites of this group onto the available protein structure provided insight into its functional significance. An epitope-based immunogen is proposed as an alternative to the NS3 epitopes in the peptide-based vaccine IC41. IMPORTANCE: Despite much experimental work on HCV, a thorough statistical study of the HCV sequences for the purpose of immunogen design was missing in the literature. Such a study is vital to identify epistatic couplings among residues that can provide useful insights for designing a potent vaccine. In this work, ideas from random matrix theory were applied to characterize the statistics of substitutions within the diverse publicly available sequences of the genotype 1a HCV NS3 protein, leading to a group of sites for which HCV appears to resist simultaneous substitutions possibly due to deleterious effect on viral fitness. Our analysis leads to completely novel immunogen designs for HCV. In addition, the NS3 epitopes used in the recently proposed peptide-based vaccine IC41 were analyzed in the context of our framework. Our analysis predicts that alternative NS3 epitopes may be worth exploring as they might be more efficacious.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24760894      PMCID: PMC4054436          DOI: 10.1128/JVI.03812-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  61 in total

1.  Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection.

Authors:  H M Diepolder; J T Gerlach; R Zachoval; R M Hoffmann; M C Jung; E A Wierenga; S Scholz; T Santantonio; M Houghton; S Southwood; A Sette; G R Pape
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Mining residue contacts in proteins using local structure predictions.

Authors:  M J Zaki; Shan Jin; C Bystroff
Journal:  IEEE Trans Syst Man Cybern B Cybern       Date:  2003

3.  The hepatitis C viral NS3 protein is a processive DNA helicase with cofactor enhanced RNA unwinding.

Authors:  Phillip S Pang; Eckhard Jankowsky; Paul J Planet; Anna Marie Pyle
Journal:  EMBO J       Date:  2002-03-01       Impact factor: 11.598

4.  Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection.

Authors:  K M Chang; R Thimme; J J Melpolder; D Oldach; J Pemberton; J Moorhead-Loudis; J G McHutchison; H J Alter; F V Chisari
Journal:  Hepatology       Date:  2001-01       Impact factor: 17.425

5.  Translating HIV sequences into quantitative fitness landscapes predicts viral vulnerabilities for rational immunogen design.

Authors:  Andrew L Ferguson; Jaclyn K Mann; Saleha Omarjee; Thumbi Ndung'u; Bruce D Walker; Arup K Chakraborty
Journal:  Immunity       Date:  2013-03-21       Impact factor: 31.745

6.  Coordinated evolution of the hepatitis C virus.

Authors:  D S Campo; Z Dimitrova; R J Mitchell; J Lara; Y Khudyakov
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-09       Impact factor: 11.205

Review 7.  Hepatitis C virus-specific directly acting antiviral drugs.

Authors:  Leen Delang; Johan Neyts; Inge Vliegen; Sergio Abrignani; Petra Neddermann; Raffaele De Francesco
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

8.  Discovery of an allosteric mechanism for the regulation of HCV NS3 protein function.

Authors:  Susanne M Saalau-Bethell; Andrew J Woodhead; Gianni Chessari; Maria G Carr; Joseph Coyle; Brent Graham; Steven D Hiscock; Christopher W Murray; Puja Pathuri; Sharna J Rich; Caroline J Richardson; Pamela A Williams; Harren Jhoti
Journal:  Nat Chem Biol       Date:  2012-09-30       Impact factor: 15.040

9.  PRISM: protein interactions by structural matching.

Authors:  Utkan Ogmen; Ozlem Keskin; A Selim Aytuna; Ruth Nussinov; Attila Gursoy
Journal:  Nucleic Acids Res       Date:  2005-07-01       Impact factor: 16.971

View more
  5 in total

1.  Co-evolution networks of HIV/HCV are modular with direct association to structure and function.

Authors:  Ahmed Abdul Quadeer; David Morales-Jimenez; Matthew R McKay
Journal:  PLoS Comput Biol       Date:  2018-09-07       Impact factor: 4.475

2.  Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies.

Authors:  Syed Faraz Ahmed; Ahmed A Quadeer; Matthew R McKay
Journal:  Viruses       Date:  2020-02-25       Impact factor: 5.048

Review 3.  In silico T cell epitope identification for SARS-CoV-2: Progress and perspectives.

Authors:  Muhammad Saqib Sohail; Syed Faraz Ahmed; Ahmed Abdul Quadeer; Matthew R McKay
Journal:  Adv Drug Deliv Rev       Date:  2021-01-17       Impact factor: 17.873

4.  Evolutionary modeling reveals enhanced mutational flexibility of HCV subtype 1b compared with 1a.

Authors:  Hang Zhang; Ahmed A Quadeer; Matthew R McKay
Journal:  iScience       Date:  2021-12-08

5.  HR9: An Important Cell Penetrating Peptide for Delivery of HCV NS3 DNA into HEK-293T Cells.

Authors:  Sina Alizadeh; Shiva Irani; Azam Bolhassani; Seyed Mehdi Sadat
Journal:  Avicenna J Med Biotechnol       Date:  2020 Jan-Mar
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.